RAFAEL HOLDINGS, INC. Increase (Decrease) in Other Current Liabilities
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Other Current Liabilities of $4.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-10-31 was -$3.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-07-31 was -$27.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-04-30 was -$34.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-01-31 was -$5.00K, a 120.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2025 was -$67.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2024 was -$938.00K, a 220.10% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2023 was $781.00K, a 78.10% decline from fiscal 2022.
- RAFAEL HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2022 was $3.57M, a 2502.92% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 3 month as first filed | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-04-30 | $4.00K 10-Q · filed 2026-06-11 | ||||
| 2025-10-31 | -$3.00K 10-Q · filed 2025-12-12 | -$30.00K derived: sum of 2 quarters · filed 2025-12-12 | -$64.00K derived: sum of 3 quarters · filed 2026-06-11 | -$69.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-07-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$61.00K derived: sum of 2 quarters · filed 2026-06-11 | -$66.00K derived: sum of 3 quarters · filed 2026-06-11 | -$67.00K 10-K · filed 2025-10-29 | |
| 2025-04-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$39.00K derived: sum of 2 quarters · filed 2026-06-11 | -$40.00K 10-Q · filed 2026-06-11 | -$95.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-01-31 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$6.00K 10-Q · filed 2026-03-16 | -$61.00K derived: sum of 3 quarters · filed 2026-03-16 | -$61.00K derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-10-31 | -$1.00K 10-Q · filed 2025-12-12 | -$56.00K derived: sum of 2 quarters · filed 2025-12-12 | -$56.00K derived: sum of 3 quarters · filed 2025-12-12 | -$31.00K derived: sum of 4 quarters · filed 2025-12-12 | |
| 2024-07-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$55.00K derived: sum of 2 quarters · filed 2025-10-29 | -$30.00K derived: sum of 3 quarters · filed 2025-10-29 | -$938.00K 10-K · filed 2025-10-29 | |
| 2024-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | $25.00K derived: sum of 2 quarters · filed 2025-06-11 | -$883.00K 10-Q · filed 2025-06-11 | ||
| 2024-01-31 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$883.00K 10-Q · filed 2025-03-14 | |||
| 2023-10-31 | -$908.00K 10-Q · filed 2024-12-11 | ||||
| 2023-07-31 | $781.00K 10-K/A · filed 2024-12-20 | ||||
| 2023-01-31 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | $30.00K 10-Q · filed 2024-03-14 | $3.08M derived: sum of 3 quarters · filed 2024-03-14 | $3.50M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-10-31 | $103.00K 10-Q · filed 2023-12-14 | $3.15M derived: sum of 2 quarters · filed 2023-12-14 | $3.57M derived: sum of 3 quarters · filed 2023-12-14 | $3.79M derived: sum of 4 quarters · filed 2023-12-14 | |
| 2022-07-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $3.47M derived: sum of 2 quarters · filed 2023-10-30 | $3.69M derived: sum of 3 quarters · filed 2023-10-30 | $3.57M 10-K · filed 2023-10-30 | |
| 2022-04-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $638.00K derived: sum of 2 quarters · filed 2023-06-13 | $514.00K 10-Q · filed 2023-06-13 | $531.00K derived: sum of 4 quarters · filed 2023-06-13 | |
| 2022-01-31 | $222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $98.00K 10-Q · filed 2023-03-14 | $115.00K derived: sum of 3 quarters · filed 2023-03-14 | $188.00K derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-10-31 | -$124.00K 10-Q · filed 2022-12-13 | -$107.00K derived: sum of 2 quarters · filed 2022-12-13 | -$34.00K derived: sum of 3 quarters · filed 2022-12-13 | $135.00K derived: sum of 4 quarters · filed 2022-12-13 | |
| 2021-07-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $90.00K derived: sum of 2 quarters · filed 2022-10-31 | $259.00K derived: sum of 3 quarters · filed 2022-10-31 | $137.00K 10-K · filed 2022-10-31 | |
| 2021-04-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $242.00K derived: sum of 2 quarters · filed 2022-06-14 | $120.00K 10-Q · filed 2022-06-14 | ||
| 2021-01-31 | $169.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $47.00K 10-Q · filed 2022-03-17 | |||
| 2020-10-31 | -$122.00K 10-Q/A · filed 2022-02-28 | $26.00K 10-Q · filed 2020-12-15 | |||
| 2020-07-31 | $88.00K 10-K · filed 2021-10-18 | ||||
| 2019-10-31 | -$12.00K 10-Q · filed 2020-12-15 | -$4.00K derived: sum of 2 quarters · filed 2020-12-15 | -$48.00K derived: sum of 3 quarters · filed 2020-12-15 | -$3.00K derived: sum of 4 quarters · filed 2020-12-15 | |
| 2019-07-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | -$36.00K derived: sum of 2 quarters · filed 2020-10-29 | $9.00K derived: sum of 3 quarters · filed 2020-10-29 | $3.00K 10-K · filed 2020-10-29 | |
| 2019-04-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $1.00K derived: sum of 2 quarters · filed 2020-06-09 | -$5.00K 10-Q · filed 2020-06-09 | -$7.00K derived: sum of 4 quarters · filed 2020-06-09 | |
| 2019-01-31 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | $39.00K 10-Q · filed 2020-03-05 | $37.00K derived: sum of 3 quarters · filed 2020-03-05 | $44.00K derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-10-31 | -$6.00K 10-Q · filed 2019-12-09 | -$8.00K derived: sum of 2 quarters · filed 2019-12-09 | -$1.00K derived: sum of 3 quarters · filed 2019-12-09 | $9.00K derived: sum of 4 quarters · filed 2019-12-09 | |
| 2018-07-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $5.00K derived: sum of 2 quarters · filed 2019-10-04 | $15.00K derived: sum of 3 quarters · filed 2019-10-04 | -$10.00K 10-K · filed 2019-10-04 | |
| 2018-04-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $17.00K derived: sum of 2 quarters · filed 2019-06-05 | -$8.00K 10-Q · filed 2019-06-05 | $10.00K derived: sum of 4 quarters · filed 2019-06-05 | |
| 2018-01-31 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | -$15.00K 10-Q · filed 2019-03-12 | $3.00K derived: sum of 3 quarters · filed 2019-03-12 | ||
| 2017-10-31 | -$25.00K 10-Q · filed 2018-12-10 | -$7.00K derived: sum of 2 quarters · filed 2018-12-10 | |||
| 2017-07-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $11.00K 10-K · filed 2018-10-15 | |||
| 2017-04-30 | -$7.00K 10-Q · filed 2018-06-11 | ||||
| 2016-07-31 | $17.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |